Atlas Trials

Potential Role of Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients: Impact of Ferretin and D -Dimer.

Clinical trial NCT06080750 · UNKNOWN

Trial details

NCT number
NCT06080750
Sponsor
Assiut University
Status
UNKNOWN
Study type
OBSERVATIONAL
Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
Start date
2023-01-01
Primary completion
2024-01-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.